Legal Representation
Attorney
Daniel Tychonievich
USPTO Deadlines
Next Deadline
1647 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240625)
Due Date
June 25, 2030
Grace Period Ends
December 25, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 25, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jun 25, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 9, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 9, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 20, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 4, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 1, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 31, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 31, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 1, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 1, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 1, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 19, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 12, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 20, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Medication counseling in the nature of providing a flexible framework of evidence-based medication strategies for managing the care and costs of treating employees living and working with chronic conditions
First Use Anywhere:
20210300
First Use in Commerce:
20210300
Class 045
Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication by providing a flexible framework of evidence-based medication strategies for managing the care and costs of treating employees living and working with chronic conditions
First Use Anywhere:
20210300
First Use in Commerce:
20210300
Classification
International Classes
044
045
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CLINICAL"